News Home
Premarket Mover: Collegium Pharmaceutical Inc (COLL) Down 12.07%
Tuesday, February 07, 2023 06:56 AM | InvestorsObserver Analysts
Collegium Pharmaceutical Inc (COLL) is lower by Tuesday morning, with the stock falling -12.07% in pre-market trading to 24.4.
COLL's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, the stock ranks higher than 94% of stocks.
Collegium Pharmaceutical Inc has fallen 3.14% over the past month, closing at $28.45 on January 10. During this period of time, the stock fell as low as $27.38 and as high as $30.22. COLL has an average analyst recommendation of Strong Buy. The company has an average price target of $32.25.
COLL has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on COLL!
Collegium Pharmaceutical Inc has a Long-Term Technical rank of 97. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 3% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 143 by this metric, COLL ranks better than 143% of stocks.
Important Dates for Investors in COLL:
-Collegium Pharmaceutical Inc is set to release earnings on 2/23/2023. Over the last 12 months, the company has reported EPS of $-1.09.
-We do not have a set dividend date for Collegium Pharmaceutical Inc at this time.
Click Here To Get The Full Report on Collegium Pharmaceutical Inc (COLL)
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
You May Also Like
